Cases & Deals

  • Home
  • Practices
  • Debiopharm and M Ventures co-lead €15.5 million Series A financing of Iktos

Share

Debiopharm and M Ventures co-lead €15.5 million Series A financing of Iktos

March 2023

Client(s) Debiopharm Innovation Fund, M Ventures, and Omnes Capital

Jones Day advised Debiopharm Innovation Fund, M Ventures, and Omnes Capital in the €15.5 million Series A financing of Iktos, a company specializing in artificial intelligence for new drug discovery. This Series A will enable Iktos to expand its AI technology platform and launch Iktos Robotics; an AI-driven automated end-to-end drug discovery service.

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.